AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Summary
- Medical logistics stock Andlauer has soared over 127 per cent year-to-date (YTD).
- Andlauer stocks offer a return on equity (ROE) of 25.28 per cent.
- CloudMD stocks are up nearly 173 per cent since its listing in June this year.
BioNTech has reportedly claimed that the COVID-19 vaccine shots, it developed along with Pfizer, can be delivered within 24 hours to Canada. The vaccine is currently awaiting Health Canada’s emergency use approval. But once Canada gets the vaccine, can it be distributed fairly, and what sort of logistic support would it require?
In these circumstances, Canadian healthcare services and medical distribution companies will come into the picture to handle the crucial responsibilities.
In the wake of this development, let us analyze the following healthcare service provider and medical distributor stocks: CloudMD and Andlauer Healthcare.
Andlauer Healthcare Group Inc. (TSX:AND)
Current Stock Price: C$ 40.33
Andlauer provides customized transportation and healthcare logistics while engaging in distribution, warehousing, delivery, and other related services for medical organizations.
This medical logistics stock has zoomed over 127 per cent year-to-date (YTD). In the last six months, the stock has returned nearly 25 per cent growth. In its last trading session, the company stocks have jumped over 7 per cent.
The healthcare stocks deliver a return on equity (ROE) of 25.28 per cent and a return on assets (ROA) of 12.27 per cent. Its current price-to-cashflow ratio is 19.60, and debt-to-earnings (D/E) ratio is 1.52. The company offers a quarterly cash dividend of C$ 0.05 per stock. The current earnings-per-share are C$ 0.80, as per the TMX portal.
Andlauer registered revenue of C$ 75.8 million in the third quarter of 2020, a rise of 7 per cent from C$ 70.8 million in Q3 2019. Its net income and comprehensive income were C$ 8.6 million, up 10.7 per cent compared to C$ 7.8 million in Q3 2019. The company posted an EBITDA of C$ 20.2 million, up 13 per cent year-over-year (YoY).
Year-to-date chart of AND Stock (Source: Refinitiv, Thomson Reuters)
CloudMD Software & Services Inc. (TSXV:DOC)
Current Stock Price: C$ 2.07
CloudMD Software & Services Inc is a Software-as-a-Service (SaaS)-based tech healthcare company that provides patients access to all aspects of their care from their smartphone and computer.
The tech medical stock is up almost 173 per cent since its first day of trading on June 5, 2020. In the last three months, the stock grew by 23 per cent.
Its 10-day average stock trading volume is 1.81 million units. The company has been ranked highly on TMX’s junior healthcare stocklist.
Its price-to-book ratio is 12.938, and its present D/E ratio is 0.21. CloudMD’s current market cap is nearly C$ 339 million, as per TMX data.
In the third quarter of 2020, the cloud-based healthcare company reported total revenue of C$ 3.4 million, up 55 per cent YoY. The revenue from SaaS solutions alone was C$ 0.5 million in Q3 2020, compared to C$0.4 million in Q3 2019, up 22 per cent.
